Spiropyran‐Based Photoisomerizable α‐Amino Acid for Membrane‐Active Peptide Modification

Abstract

AbstractPhotoisomerizable peptides are promising drug candidates in photopharmacology. While azobenzene‐ and diarylethene‐containing photoisomerizable peptides have already demonstrated their potential in this regard, reports on the use of spiropyrans to photoregulate bioactive peptides are still scarce. This work focuses on the design and synthesis of a spiropyran‐derived amino acid, (S)‐2‐amino‐3‐(6'‐methoxy‐1',3',3'‐trimethylspiro‐[2H‐1‐benzopyran‐2,2'‐indolin‐6‐yl])propanoic acid, which is suitable for the preparation of photoisomerizable peptides. The utility of this amino acid is demonstrated by incorporating it into the backbone of BP100, a known membrane‐active peptide, and by examining the photoregulation of the membrane perturbation by the spiropyran‐containing peptides. The toxicity of the peptides (against the plant cell line BY‐2), their bacteriotoxicity (E. coli), and actin–auxin oscillator modulation ability were shown to be significantly dependent on the photoisomeric state of the spiropyran unit.